Back to top

earnings: Archive

Zacks Equity Research

MercadoLibre Q2 Earnings Call Focuses on Engagement Over Margin

MELI's Q2 call reinforces its focus on engagement and ecosystem scale over near-term margins as commerce, credit and AI returns support investment.

MELIPositive Net Change

Zacks Equity Research

TTMI Q2 Earnings Call Highlights AI Demand

TTM Technologies enters the second half with AI and defense demand, an N+M PCB ramp and capacity investments supporting a stronger 2026 outlook.

TTMIPositive Net Change

Zacks Equity Research

WDC Q4 Earnings Call Highlights AI Storage Demand

Western Digital's AI storage demand, pricing gains and higher-capacity products support another growth quarter and continued margin expansion.

WDCNegative Net Change

Zacks Equity Research

ROK Q3 Earnings Call Signals Broader Demand, Higher Costs

Rockwell Automation's broader end-market demand, stronger margins and raised fiscal 2026 outlook signal momentum, even as inflation and tariffs increase costs.

ROKPositive Net Change

Zacks Equity Research

EOG Q2 Earnings Call Highlights UAE Progress & Cost Discipline

EOG Resources' record cash generation, promising UAE wells and tight cost controls frame a disciplined plan balancing selective growth, flexibility and cash returns.

EOGPositive Net Change

Zacks Equity Research

AVT Q4 Earnings Call Highlights Broad Demand Recovery

Avnet's broad-based recovery, rising bookings and longer lead times support a fiscal 2027 outlook driven mainly by units and mix.

AVTNegative Net Change

Zacks Equity Research

MCK Q1 Earnings Call Centers on Pharma-Led Guidance Raise

McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand, oncology growth and disciplined spending shape the call.

MCKPositive Net Change

Zacks Equity Research

KLIC Q2 Earnings Call Highlights TCB Capacity Expansion

KLIC accelerates TCB expansion as demand rebounds, targeting over $100 million in fiscal 2026 revenue and $400 million in annual system capacity.

KLICPositive Net Change

Zacks Equity Research

NVO Q2 Earnings Call Centers on Wegovy Pill and Outlook Lift

Novo Nordisk lifts its 2026 outlook as Wegovy pill demand accelerates, even as U.S. pricing, patent losses and competition pressure the second half.

NVONegative Net Change

Zacks Equity Research

BWA Q2 Earnings Call Highlights Margin Gains and Industrial Push

BorgWarner pairs stronger margins and higher 2026 earnings guidance with faster data-center investment targeting production in 2027.

BWAPositive Net Change